Jennifer Smith is the editor of Oncology Practice, part of MDedge Hematology/Oncology. She was previously the editor of Hematology Times, an editor at Principal Investigators Association, and a reporter at The Oneida Daily Dispatch. She has a BS in journalism.
News
Combo disappoints in metastatic, castration-resistant prostate cancer
Adding saracatinib to docetaxel increased toxicity without improving efficacy.
News
Treatments linked to death in COVID patients with thoracic cancers
Prior treatment with steroids, anticoagulants, chemotherapy alone, or chemo plus immunotherapy were all associated with an increased risk of death...
News
NSCLC: FDA approves capmatinib and companion assay
Capmatinib is the first FDA-approved treatment for NSCLC with MET exon 14 skipping mutations.
News
Mitomycin approved for low-grade upper tract urothelial cancer
The FDA’s fast-track approval of mitomycin is based on results from the phase 3 OLYMPUS trial.
News
Barriers to clinical trial participation revealed by gynecologic cancer patients
A survey suggests a lack of discussion about clinical trials between doctors and patients with gynecologic cancers.
News
Doublet may be beneficial in wild-type, advanced NSCLC
About 77% of patients achieved a partial response or had stable disease on combination apatinib and vinorelbine.
News
Drug reduces oral mucositis without affecting tumor control
Locoregional control, distant metastasis, and survival rates were similar in patients who received the drug, GC4419, and those who did not.